A detailed history of Deutsche Bank Ag\ transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 84,678 shares of DVAX stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,678
Previous 72,543 16.73%
Holding current value
$1.09 Million
Previous $814,000 15.85%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.05 - $11.61 $121,956 - $140,887
12,135 Added 16.73%
84,678 $943,000
Q2 2024

Aug 14, 2024

SELL
$10.73 - $12.58 $101,816 - $119,371
-9,489 Reduced 11.57%
72,543 $814,000
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $141,417 - $181,063
12,087 Added 17.28%
82,032 $1.02 Million
Q4 2023

Feb 14, 2024

SELL
$13.09 - $14.98 $12,788 - $14,635
-977 Reduced 1.38%
69,945 $977,000
Q3 2023

Nov 09, 2023

BUY
$12.64 - $14.99 $104,975 - $124,491
8,305 Added 13.26%
70,922 $1.05 Million
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.17 $223,033 - $298,208
-22,643 Reduced 26.56%
62,617 $809,000
Q1 2023

May 15, 2023

BUY
$9.44 - $11.88 $235,669 - $296,584
24,965 Added 41.4%
85,260 $836,000
Q4 2022

Feb 13, 2023

BUY
$10.27 - $13.29 $64,957 - $84,059
6,325 Added 11.72%
60,295 $641,000
Q3 2022

Nov 14, 2022

SELL
$9.93 - $17.44 $120,689 - $211,965
-12,154 Reduced 18.38%
53,970 $564,000
Q2 2022

Aug 11, 2022

SELL
$7.45 - $12.83 $33,957 - $58,479
-4,558 Reduced 6.45%
66,124 $832,000
Q1 2022

May 13, 2022

SELL
$9.75 - $14.44 $1.04 Million - $1.53 Million
-106,268 Reduced 60.06%
70,682 $767,000
Q4 2021

Feb 11, 2022

SELL
$13.17 - $20.94 $4.95 Million - $7.87 Million
-375,905 Reduced 67.99%
176,950 $2.49 Million
Q3 2021

Nov 04, 2021

BUY
$9.16 - $19.83 $3.11 Million - $6.73 Million
339,448 Added 159.06%
552,855 $10.6 Million
Q2 2021

Aug 11, 2021

SELL
$7.25 - $10.99 $658,365 - $997,990
-90,809 Reduced 29.85%
213,407 $2.1 Million
Q1 2021

May 13, 2021

BUY
$4.57 - $11.18 $132,671 - $324,566
29,031 Added 10.55%
304,216 $2.99 Million
Q4 2020

Feb 16, 2021

BUY
$3.73 - $5.6 $91,246 - $136,992
24,463 Added 9.76%
275,185 $1.23 Million
Q3 2020

Nov 12, 2020

SELL
$4.32 - $11.7 $2.18 Million - $5.9 Million
-504,248 Reduced 66.79%
250,722 $1.08 Million
Q2 2020

Aug 13, 2020

SELL
$2.94 - $9.1 $866,509 - $2.68 Million
-294,731 Reduced 28.08%
754,970 $6.7 Million
Q1 2020

May 14, 2020

BUY
$2.27 - $6.2 $1.84 Million - $5.02 Million
809,934 Added 337.8%
1,049,701 $3.71 Million
Q4 2019

Feb 14, 2020

BUY
$3.46 - $6.93 $97,232 - $194,746
28,102 Added 13.28%
239,767 $1.37 Million
Q3 2019

Nov 14, 2019

SELL
$2.69 - $4.85 $568,136 - $1.02 Million
-211,203 Reduced 49.95%
211,665 $755,000
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $565,874 - $1.22 Million
155,034 Added 57.88%
422,868 $1.69 Million
Q1 2019

May 15, 2019

BUY
$7.08 - $12.09 $526,369 - $898,843
74,346 Added 38.42%
267,834 $1.96 Million
Q4 2018

Feb 14, 2019

SELL
$8.14 - $13.28 $2.45 Million - $4 Million
-301,437 Reduced 60.91%
193,488 $1.77 Million
Q3 2018

Dec 21, 2021

BUY
$11.85 - $16.0 $2.26 Million - $3.05 Million
190,532 Added 62.59%
494,925 $6.14 Million
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $60,435 - $81,600
5,100 Added 1.7%
304,393 $3.77 Million
Q2 2018

Apr 21, 2020

BUY
$15.15 - $20.75 $352,722 - $483,101
23,282 Added 8.44%
299,293 $4.56 Million
Q2 2018

Aug 14, 2018

SELL
$15.15 - $20.75 $17.2 Million - $23.5 Million
-1,133,475 Reduced 80.42%
276,011 $4.21 Million
Q1 2018

Oct 18, 2019

BUY
$14.65 - $19.9 $2.8 Million - $3.81 Million
191,431 Added 15.72%
1,409,486 $28 Million
Q1 2018

May 15, 2018

SELL
$14.65 - $19.9 $3.06 Million - $4.16 Million
-208,863 Reduced 14.64%
1,218,055 $24.2 Million
Q4 2017

Feb 14, 2018

BUY
$17.3 - $24.08 $577,647 - $804,031
33,390 Added 2.4%
1,426,918 $26.7 Million
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $21.2 Million - $30 Million
1,393,528
1,393,528 $30 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.